Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II StudyNaval Daver, Hagop M. Kantarjian, Jörge E. Cortes et al.|Cancer Discovery|2018Cited by 570
Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell LymphomaPreetesh Jain, Michael Wang, L. Jeffrey Medeiros et al.|Journal of Clinical Oncology|2021Cited by 82